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ABSTRACT

Escherichia coli is used intensively for recombinant protein production due to its
many unique advantages, but one key challenge with the use of E. coli is the tendency of
recombinant proteins to misfold and aggregate into insoluble inclusion bodies (IBs). The
presence of IBs stresses cells and can hinder overall growth. Additionally, IBs contain
high concentrations of recombinant protein in an inactive form and thus require recovery
steps to salvage functional recombinant protein. Currently, no universally effective
method exists to prevent IB formation in recombinant E. coli. Further research into the
gene expression response to insoluble recombinant protein may provide insight into
critical cellular mechanisms that could be leveraged to minimize IB formation. This
study was focused on characterizing the dynamic transcriptional response of E. coli in the
initial stages of IB formation, as previous studies have only characterized gene
expression changes after IBs had accumulated.
In this study, DNA microarrays were used to compare the E. coli gene expression
response to soluble and to insoluble recombinant protein production. Genes involved in
many several cellular functionalities were differentially expressed due to the production
of insoluble recombinant protein. As expected and previously reported, expression levels
of many classical heat-shock genes increased, including protein folding chaperones and
proteases. Additionally, cells increased expression levels of protein synthesis-related
genes and of genes involved in energy-deriving pathways. Interestingly, expression
levels decreased for many transmembrane transporter genes for many substances not
found in the culture medium, while several genes involved in catabolic pathways for
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these substances also decreased in expression. Additionally, over a third of the
differentially expressed genes were classified as putative genes, indicating that IB stress
regulates many genes that have not been extensively studied. Taken together, the results
of this study indicate that IB formation in recombinant E. coli is a complex issue that not
only induces the heat-shock genes but also directly causes the cells to increase protein
and energy synthesis, while streamlining transport and catabolic processes. Further study
of the differentially expressed putative genes could provide deeper insight into the
dynamic response to IB formation.
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CHAPTER ONE
PROJECT INTRODUCTION

This thesis describes the analysis of the dynamic genomic response of
Escherichia coli to recombinant protein insolubility. This project was intiated by Mary
Alice Salazar. I began work on this project in February 2012. The majority of this thesis
will be submitted as a peer-reviewed journal publication by the summer of 2013. The
authors of the journal manuscript will be: Faraz Baig, Lawrence P. Fernando, Mary Alice
Salazar, Rhonda Powell, Terri Bruce, and Sarah W. Harcum. The following describes the
contributions of each author of the journal manuscript:
1. Mary Alice Salazar


Conducted growth experiments of E. coli pTVP1GFP and pGFPCAT
cultures used to obtain the RNA for the DNA microarrays



Quantified the quality of RNA used for the DNA microarrays



Conducted the flow cytometry analysis of VP1GFP cultures

2. Dr. Lawrence Fernando


Isolated total RNA for the DNA microarrays



Quantified the total RNA isolated



Synthesized and quantified the cDNA for the DNA microarrays

3. Dr. Sarah W. Harcum (MS committee chair)


Isolated total RNA for DNA microarrays



Assisted with experimental planning
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Assisted with journal manuscript preparation

4. Rhonda Powell and Dr. Terri Bruce


As part of future work, will obtain immunofluorescence images for E.
coli pTVP1GFP and pGFPCAT cultures to localize the TVP1, GFP,
and CAT proteins.

All DNA microarrays were processed at Florida State University’s NimbleGen Certified
Microarray Facility. I was responsible for quantifying CAT activity in E. coli pGFPCAT
cultures; importing the DNA microarray data into ArrayStar; analyzing the gene
expression data; and preparing the journal manuscript.
This Master’s thesis is divided into six chapters. Chapter I briefly describes the
project history and the responsibilities of the key contributors. Chapter II provides a
background and the study objectives. Chapter III describes the materials and methods
used and will be included in the journal manuscript. Chapter IV describes the results and
discussion that will be included in the journal manuscript. Chapter V describes the
conclusions of the gene expression analysis. Chapter VI describes future work in the
immunofluorescence localization of the proteins which will be included in the journal
manuscript. Appendix A contains a list of differentially expressed genes which will be
included in the journal manuscript. Appendix B contains select gene expression profiles
which will be included as supplementary material for the journal manuscript.
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CHAPTER TWO
BACKGROUND AND STUDY OBJECTIVE

2.1 INTRODUCTION TO RECOMBINANT PROTEINS
Starting in the 1970s, scientists broke new ground and discovered how to
intentionally manipulate cells at the genetic level. This advent led to the birth of genetic
engineering. At its core, genetic engineering consists of isolating a gene of interest and
recombining it with the DNA of another host. Once in the new host, the DNA is referred
to as ”recombinant DNA,” and the protein(s) the gene encode for are referred to as
“recombinant protein(s).” The advent of recombinant DNA has revolutionized protein
production methodologies. Proteins that previously could only be harvested from human
and animal donors can now be safely mass-produced in fermenters (Shuler 2002, Chou
2007).

How to Make a Recombinant Protein
In order to make a recombinant protein, the first step is to obtain the gene of
interest. One of the earliest and most common methods used to achieve this task involves
the use of the enzyme reverse transcriptase to synthesize a DNA molecule. In this
method, cells that generate the protein of interest are harvested, and the mRNA is isolated
from these cells. Reverse transcriptase then reverse transcribes the mRNA, yielding a
complementary of DNA (known as cDNA) (Shuler 2002). Other common methods for
gene isolation include chemical synthesis of the exact nucleotide sequence (Hughes et al

3

2011) and a method known as “shotgun cloning,” where restriction enzymes are used to
fragment DNA from a host organism and subsequent screening methods filter impurities
in order to yield the gene of interest (Shuler 2002). All of the various gene isolation
methods differ in several factors, including specificity, speed, and costs. These factors
must be evaluated when choosing a particular cloning method to utilize.
Once the gene of interest is obtained, it is joined onto a DNA carrier known as a
“vector.” The vector allows the gene of interest to pass into a cell and to become
incorporated into cellular DNA. Most commonly, plasmids are used as vectors,
especially in bacterial cells, such as Escherichia coli. Plasmids are DNA molecules
which replicate independently of a host genome. Since plasmids replicate independently
of the host genome, there can be multiple copies of plasmids within a single cell,
allowing for high expression levels of recombinant proteins. Several enzymes are used to
incorporate the target gene into plasmids, including restriction enzymes, ligases, and
polymerases. Once modified, the vectors are then inserted into host cells.
Transformation is a frequently used method, where free DNA segments are taken up by
the cells. Once the vectors are incorporated into the host cells, recombinant protein
production can begin (Shuler 2002, Hanahan 1983).

Significance of Recombinant DNA Technology
Recombinant DNA technology allows for controlled manipulation of cellular
DNA and DNA expression. Industrially, the main application of recombinant DNA
technology has been to produce therapeutic proteins, such as human insulin, Factor VIII-
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C, human growth hormone, erythropoietin, and various vaccines. Other uses for
recombinant proteins include food processing, industrial catalysts, and animal husbandry
(Shuler 2002).
To mass-produce proteins for industrial application, cells with recombinant DNA
are grown in cultures, with the primary goal being to produce as much of the recombinant
protein as possible, in as short of a time-frame as possible. The cells that are most
frequently used to produce recombinant proteins are harvested from microbial sources
(most notably, E. coli), Chinese hamster ovary (CHO) cells, plants, and yeasts. Various
downstream process steps are then utilized to purify the protein (Chu and Robinson 2001,
Doran 2000, Goodrick et al 2001, Wang et al 2001, Jana 2005).

2.2 ESCHERICHIA COLI AND INCLUSION BODIES
E. coli is a very popular organism to use for recombinant protein production
because of its many unique advantages: high growth rates, high expression levels, low
costs, simple growth medium, reasonably low levels of proteolytic degradation, and good
overall safety. However, one of the biggest problems encountered with E. coli-produced
recombinant proteins is that very often, the proteins do not fold properly and
consequently become insoluble. Misfolded proteins are functionally compromised and
tend to form dense, insoluble aggregates known as inclusion bodies (IBs) inside the cell.
IBs have proven to be problematic for recombinant protein production (Shuler 2002,
Baneyx 1999, Mergulhao 2005, Baneyx 2004, Kyratsous 2012). This study primarily
focuses on issues related to the presence of IBs.
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Pathophysiology of IBs
The average E. coli cell produces about 60,000 polypeptide chains per minute
(Lorimer 1996). With such a rapid rate of protein production, protein folding can be a
challenge. Large, multidomain proteins are particularly problematic due to more
intensive folding requirements in comparison to smaller, simpler proteins. To cope with
these challenges, E. coli cells are equipped with protein folding helpers. These include
molecular chaperones, which assist in protein folding by providing a favorable
environment for domains within proteins to interact appropriately, and folding catalysts,
which are specialized enzymes that catalyze reactions necessary to fold polypeptide
chains (Baneyx 2004).
Sometimes, the protein folding helpers of E. coli are not able to properly fold a
protein. Recombinant proteins, in particular, tend to overwhelm the folding machinery
due to high expression rates and due to lack of biological necessity for E. coli survival.
This issue is exacerbated when strong promoters are used to increase protein expression
rates in order to increase yields. One recent study suggested that on average, only about
30% of E. coli-produced recombinant proteins are expressed in soluble, folded form
(Yang et al 2011). While terminally misfolded proteins can undergo proteolysis to
prevent buildup, highly expressed recombinant proteins that misfold frequently tend to
aggregate into IBs. Since IBs are often protease-resistant due to strong interactions
between hydrophobic surfaces in the concentrated intracellular environment, cells only
have a limited ability to remove IBs post-formation (Kyratsous 2012, Baneyx 2004).
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Attempts to Control IB Formation
IBs pose a challenge to the recombinant protein production process. The presence
of protease-resistant IBs induces stress-related responses in the cells and also can hinder
overall cell growth (Ventura 2006, Chou 2007, Lesley 2002). Additionally, since IBs
contain large amounts of the target recombinant protein, much effort goes into recovering
these recombinant proteins from IBs. However, the recovery processes remain timeconsuming and inefficient, with denaturation, refolding, and purification steps required to
obtain properly folded recombinant protein (Choi 2004, Georgiou 1996). In addition to
the added costs of these steps, yields at each step can be low: on average, only about 1525% of the total recombinant protein contained in IBs is recovered as functional protein
(Zhang et al 2009). For these reasons, many attempts have been made to prevent IB
formation.
One common approach to controlling IB formation is to simply down-regulate
protein expression to ease the workload on the cellular protein-folding machinery.
Down-regulated protein expression can be accomplished in many ways, including
through the use of different transcription promoters, through culturing cells in less
nutrient-dense growth medium, or through lower cell culture temperatures that slow gene
transcription/translation. Overall, while down-regulating protein expression does reduce
the occurrence of IBs, it comes at the expense of not being able to fully exploit the
cellular protein-producing capabilities (Baneyx 2004, Chou 2007).
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In order to reduce IB formation without sacrificing final protein yield, many
attempts have been made to improve recombinant protein solubility. Manipulation of
secretory pathways, fusion of soluble proteins, growth supplementation with essential
cofactors, and substitution of specific amino acid residues have all had varying degrees of
success in improving recombinant protein solubility, but there still are no universally
applicable methods (Mergulhao 2005, Baneyx 2004, Choi 2004, Hammarstrom 2002,
Ghosh 2002). An additional approach to improving recombinant protein solubility is
through the increase of folding chaperones. For example, co-expression of folding
chaperones with the desired recombinant protein can increase protein solubility. Also,
certain chemicals added to the growth medium can increase chaperone expression by
inducing a heat-shock-like response, consequently enhancing the solubility of IB-prone
proteins. Most notably, ethanol can be used to achieve this effect (Chou 2007,
Oganesyan 2007). While strategies that increase the expression of chaperones can reduce
IB formation, there have been instances of overexpressed chaperones yielding
undesirable proteolytic effects on the protein of interest because some chaperones, such
as the DnaKJ and GroELS protein complexes, have dual roles of modulating protein
folding and enhancing proteolysis (Kyratsous 2012, Choi 2004, Martínez-Alonso 2010,
de Marco 2007, Thomas and Baneyx 1997, Sherman and Goldberg 1992). Thus,
overexpressing chaperones is not yet a comprehensively applicable method.
Over the last 20 years, many advancements have been made in improving
recombinant protein solubility and thereby controlling IB formation. However, there
have been no unanimously effective methods. Since E. coli is simply a living organism
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responding to an environmental stressor (in this case, insoluble recombinant protein),
further research into the bacterial genomic response to insoluble recombinant protein
expression would represent a key step towards devising practical methods to minimize IB
formation.

2.3 GENE EXPRESSION ANALYSIS WITH DNA MICROARRAYS
Measurements of gene expression levels for an organism (also known as gene
expression profiling or transcriptome analysis) can provide a wealth of knowledge the
genomic behavior, elucidating the underlying mechanisms for the observed phenotypic
behavior of an organism at macroscopic levels. When it comes to producing recombinant
proteins, knowledge of how a cell responds to different environments allows one to
manipulate the cellular genome and/or the culture environment in a manner conducive to
maximizing protein production (Chou 2007, Yeung 2002).

Gene Expression Analysis Methods
Many methods can be used to analyze the gene expression of an organism. Most
of these methods rely on quantifying nucleotide hybridization pairing between DNADNA or DNA-RNA sequences. Approaches to gene expression analysis can typically be
classified as either “low-throughput” or “high-throughput” based on the number of genes
directly measured. “Low-throughput” methods are used to quantify the behavior of a few
targeted genes, such as a set of genes known to be activated by a specific stressor or the
genes involved with a specific metabolic process. Low-throughput methods can be used
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to analyze these limited-in-scope gene sets. Gel-based assays (such as Northern blots and
Southern blots), quantitative PCR (polymerized chain reaction) primer extension, and
RNase protection assays are all common approaches and all operate by estimating the
quantity of mRNA or protein being expressed (Brown 2001, Taniguchi 2001, Spurgeon
2008, Nuber 2005). However, when it is desirable to measure the expression levels of the
entire genome of an organism, low-throughput gene expression methods are not feasible.
For simultaneously estimating expression levels of thousands of genes, “highthroughput” methods must be employed. In the 1990s, DNA microarrays were
introduced as a high-throughput approach to gene expression analysis and have since
gained widespread usage in the field (Nuber 2005).

DNA Microarrays
DNA microarrays are an arrangement of unique DNA molecules, known as
probes, organized onto a small chip. To analyze the gene expression levels in cells, the
total RNA is harvested from the cells. The mRNA in the total RNA is converted to
complementary DNA (cDNA), which is much more stable than the mRNA. The cDNA
is contacted with the probes on the microarray chip. When a cDNA strand encounters a
probe with a complementary base-pair sequence, hydrogen bonds are formed, resulting in
a stable conformation; this process is known as “hybridization.” Various labeling
techniques can be used to determine the hybridization levels of the various probes. A
higher signal from a particular probe is indicative of a higher quantity of cDNA with the
complementary base sequence of that probe, which correlates back to high gene
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expression levels in the cells. A single microarray chip contains hundreds to thousands
of different probes and can therefore be used to quantitatively measure gene expression
levels of a large portion of the genome of an organism (Baldi and Hatfield 2002).

Conducting a DNA Microarray Experiment
In order to conduct a DNA microarray experiment, the mRNA must first be
harvested from the cells of interest. Many standard procedures exist for harvesting RNA,
including protocols specific for total RNA and mRNA (Baldi and Hatfield 2002, Reddy
and Gilman 2001). The RNA extraction process must be performed with the utmost care
due to the liable nature of RNA. Many factors can degrade the harvested RNA, including
prolonged contact with cellular enzymes (particularly RNases); temperature and osmotic
variations during processing steps, and contamination of samples with exogenous RNase
from the environment. Accordingly, the best approach for RNA isolation includes quick
preservation of cellular material. Several RNA isolation methods exist to preserve RNA
from cells and to separate the RNA from cellular components, particularly genomic
DNA. There are many commercial RNA purification kits, such as the RNeasy Protect
Bacteria Minikit from Qiagen™ and the TRIzol® Plus RNA Purification System, that
facilitate total RNA isolation by inhibiting RNase activity, lysing cells, solubilizing
cellular components, and precipitating total RNA (Rio et al 2010, Simms et al 1993,
Masuda and Church 2002, Baldi and Hatfield 2002). Additional steps are used to isolate
mRNA, which is usually reverse transcribed to cDNA.
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Transcript Quantification
In order to quantify the mRNA level of a specific gene, the nucleotide targets
(mRNA or cDNA) are typically labeled with fluorophores. After hybridization of the
target nucleotides to the probes on the DNA microarray, an energy source can be used to
excite the flourophores. The subsequent emission energies, which are proportional to the
amount of fluorophore attached to the probes, can then be detected and digitized into a
gene expression value (Baldi and Hatfield 2002). After fluorescent emission energies of
the probes are quantified, data analysis is needed to interpret the intensity signals from
the multiple probes that represent a single gene. Software programs employ algorithms
to generate gene expression values from the detected emission energies. These
algorithms account for various sources of expected variability and background noise.
The DNA microarray software program then generates raw signal intensity data for each
gene on the array. Next, these raw data intensities can be imported into interpretation
software, such as ArrayStar™ (DNAStar, Inc.) and GeneSpring (Agilent Technologies,
Inc.). The interpretation software allows for statistical analysis and for visualization of
the data (Baldi and Hatfield 2002).

2.4 STATISTICAL ANALYSIS TOOLS
After the raw DNA microarray hybridization data are obtained, numerous
statistical tools are available to identify significantly regulated gene behavior. These
statistical tools allow researchers to take a disciplined, data-driven approach in
determining a population’s characteristics, and it removes much of the subjectivity
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inherent in the decision-making process (Ott 2010). With gene expression studies,
statistical procedures aim to balance the rate of identifying false positives and false
negatives. False positives represent genes that were not significantly regulated but were
identified as being significantly regulated, also known as a Type I error. False negatives
represent genes that were significantly regulated but were identified as unchanging, also
known as a Type II error. The next section outlines different statistical tools that are
applicable to microarray data.

Analyzing the Behavior of a Gene Between Two Different Conditions
To determine if the expression level for a particular gene is different between two
conditions, a common non-statistical approach is to simply examine the fold change of
the gene between the two conditions. For example, the mean expression level of Gene A
might be 3.5-fold higher at Time X relative to Time Z. While examining fold changes
provides a very quick and simple analysis, the obvious drawback is that it doesn’t take
into account sample variability; it simply analyzes the average values. Therefore, the
results obtained using only fold changes can be misleading in many instances (Baldi and
Hatfield 2002).
A simple statistical approach for comparing gene expression levels between two
different conditions is the Student’s t-test. The Student’s t-test compares mean gene
expression levels after normalizing the data and estimating the pooled standard deviation.
Note that the Student’s t-test can be used with log-transformed gene expression levels.
The Student’s t-test yields more statistically relevant results than the fold change analysis
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approach; however, the Student’s t-test does have limitations. Specifically, sample sizes
used in gene expression studies are usually small. As a result, findings from the
Student’s t-test are not as accurate as other statistical tests for population studies. Many
probabilistic models have been developed for population studies which improves
confidence in these types of studies (Baldi and Hatfield 2002, Ott 2010, Nadon and
Shoemaker 2002).

Analyzing the Behavior of a Gene Between More Than Two Different Conditions
If samples are collected from more than two conditions, a Student’s t-test would
have to be performed between every single possible pairing to determine differential
expression between conditions. This approach can clearly become very tedious for
studies with many conditions. More importantly, if a Student’s t-test is used with a
confidence level of 95%, there is a 5% chance of making a Type I error. If two Student’s
t-tests are run at 95% confidence, each individual test has a 5% probability of a Type I
error, so the probability that a Type I error has been made on at least one of the two tests
is actually greater than 5%. As the number of tests performed increases, the likelihood of
making at least one Type I error increases dramatically (Ott 2010).
To circumvent the issue of high Type I error probability with multiple
comparisons, Analysis of Variance (ANOVA) tests can be used. ANOVA tests compare
mean values in multiple conditions at a set confidence level. ANOVA tests operate by
comparing the sum of variances between sample means with the sum of variances within
individual samples. The premise of the ANOVA test is that if the variability between
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sample means is high relative to the variability within samples, then it is very unlikely
that all of the conditions being compared have the same mean value. If expression data is
collected for a gene over multiple conditions, ANOVA tests can quickly determine if the
gene has differential behavior in at least one of the conditions relative to the others (Ott
2010, Nuber 2005).
While an ANOVA test can determine if at least one condition has a different mean
from the rest of the conditions tested, post-hoc tests are required to determine specifically
which conditions are different. When an ANOVA test determines that one condition has
a different mean value than the remaining conditions, a pairwise comparison can be made
between the means of any two conditions. If the difference between the two conditions’
means is greater than a threshold value, then the two conditions are statistically different.
Post-hoc tests, such as the Tukey’s W and the Fisher’s LSD procedures, can be used to
determine this threshold value (Ott 2010).

Linear Regression
Linear regression is a statistical tool used to analyze the relationship between an
explanatory variable and a response variable. A linear regression model plots an
explanatory variable (x) and a response variable (y) on an x-y axis. The regression model
then makes use of a “least-squares method” to determine if a linear correlation exists
between the explanatory and the response variable. Frequently, studies are performed
where time is the explanatory variable (Ott 2010). Linear regression is a valuable tool for
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gene expression analysis because it allows for the identification of genes with subtle
time-dependent changes in response to a stimulus.

Specifying the Significance Level of Statistical Tests
All of the statistical tests discussed are conducted using a specified significance
level. The significance level of statistical tests quantifies the strength of evidence needed
to make significant conclusions. Statistical tests conducted with lower significance levels
require stronger evidence for significant results, and consequently, Type I errors are less
likely to occur with lower significance levels. Very commonly, a significance level (plevel) of 0.05 is used (which corresponds to a 5% chance of making a Type I Error), and
any statistical test with a p-value less than 0.05 (p ≤ 0.05) would yield a significant result;
however, 0.05 is not an appropriate level for all statistical tests. Different significance
levels can be used based on many factors, including the experimental conditions, the
goals of the study, and the potential consequences of making Type I errors. The context
of the study determines the optimal significance level. Significance levels ranging from
0.01 to 0.1 are most frequently used (Ott 2010).

2.5 SUMMARY AND STUDY OBJECTIVE
Recombinant protein technology has allowed genetic engineers to produce a vast
array of proteins in large quantities. E. coli has been one of the preferred cellular
factories for producing recombinant proteins, but one persistent issue with E. coli cells is
the tendency of its recombinant proteins to misfold and form IBs. IBs stress the cells, can
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hinder overall growth, and are a source of inefficiency in the recombinant protein
production process. An improved understanding of the dynamic transcriptional response
of E. coli to insoluble recombinant protein could help formulate methods to prevent IB
formation.
The objective of this study was to determine the dynamic transcriptional response
of E. coli to IB formation. DNA microarrays were used to characterize gene expression
changes due to IB formation. The gene expression changes due to expression of an IBprone protein were directly compared to gene expression changes due to expression of a
soluble recombinant protein. Since the addition of ethanol has been shown to increase
the solubility of IB-prone proteins, the effects of ethanol on the gene expression response
to IB formation was also examined.
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CHAPTER THREE
MATERIALS AND METHODS

3.1 BACTERIAL STRAIN AND PLASMIDS
E. coli MG1655 strains were obtained from the American Type Culture
Collection (ATCC). The plasmid pTVP1GFP (gift from A. Villaverde) encodes the VP1
capsid of foot-and-mouth disease (Liu et al. 2006) fused to a GFP (García-Fruitós et al.
2007). The pGFPCAT plasmid was constructed from the pTrcHis-GFPUV/CAT plasmid
(gift from W. E. Bentley) (Cha et al. 2000), where the GFPUV was replaced with the GFP
from the pTVP1GFP plasmid (Salazar et al., submitted). E. coli MG1655 were
transformed with either pTVP1GFP or pGFPCAT plasmid. Both plasmids are
ampicillin-resistant and isopropyl β-D-1-thiogalactopyranoside (IPTG) inducible through
a trc promoter.

3.2 CULTURE CONDITIONS
E. coli MG1655 transformed with the pTVP1GFP or pGFPCAT plasmid were
cultured in a minimal medium described previously (Sharma et al. 2007, Korz et al.
1995). Frozen stock (1 mL, stored at -80°C) were thawed and added to the minimal
medium containing 40 µg/mL ampicillin (Hyclone). Cells were grown overnight in a
shaker incubator (C24, New Brunswick Scientific, Inc.) at 37°C and 250 rpm to
approximately 2.5 OD. ODs were obtained at 600 nm with a spectrophotometer
(Spectronic 20 Genesys), where 1 OD is equivalent to 0.50 g dry cell weight per L.
Samples were diluted with deionized water to obtain absorbance readings in the linear
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range (0–0.25 OD). The overnight cultures were used to inoculate the experimental
flasks. Cells were added to 500 mL shake flasks (120 mL working volume). These
cultures were placed at 37°C in a water bath shaker at 200 rpm (C76, New Brunswick
Scientific,).
Cultures were induced in the mid-exponential phase (OD of 0.5) with 1 mM
IPTG. Uninduced cultures were run in parallel. For the ethanol treated cultures, ethanol
was added when the cultures reached 0.25 OD to a final concentration of 3%. Samples
were collected prior to induction (time 0) and 5, 20, 40, and 60 minutes post-induction for
the induced cultures. Samples at time 0 and 60 minutes were collected for the uninduced
cultures and the ethanol treated cultures. Samples were removed while flasks continued
to shake at 37˚C. Samples were immediately stabilized in RNA Protect Bacteria Reagent
(Qiagen, Inc.) and processed as per manual instructions. The RNA Protect solution was
removed by centrifugation (14,500 x g, 10 minutes, Hermle Labnet Z383K centrifuge),
and the cell pellets were stored in -80˚C until used for RNA isolation. All culture
conditions were conducted in biological triplicates.

3.3 PROTEIN EXPRESSION ANALYSIS
To confirm VP1GFP production, the fluorescence signal was measured
quantitatively. Samples were harvested and immediately assayed with the Influx Cell
Sorter flow cytometer (BD, Inc.) with a 488 nm Argon excitation laser and a 530/40 nm
emission filter. Fluorescence levels from 100,000 cells were averaged to obtain the
fluorescent intensity of the sample. (García-Fruitós et al. 2007). CAT activity was
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quantified using the kinetic assay described by Rodriguez and Tait (Rodriguez and Tait
1983), and adapted to a 96-well plate format (Sharma et al. 2007). Additionally, CAT
activity was confirmed by growing cells on minimal medium agar plates containing 0.61
mM chloramphenicol.

3.4 RNA ISOLATION AND CHARACTERIZATION
Total RNA isolation was performed using RNeasy Protect Bacteria Kits (Qiagen,
Inc.). A Nanodrop spectrophotometer (ND 1000 from Thermo Scientific, Inc.) was used
to quantify RNA. The Agilent 2100 Bioanalyzer with Expert Software (Version
B.02.07.SI532) with Prokaryote Total RNA series II assay settings was used to obtain
RNA integrity numbers (RIN) with the RNA 6000 Nanochip Kit. Total RNA was used to
synthesize the first strand cDNA using the Superscript First-Strand Synthesis System for
RT-PCR (Invitrogen, Inc) as per the Nimblegen instruction manual (Version 3.2). The
RNA 6000 Nanochip Kit was also used to quantify mRNA (using the mRNA protocol)
after second strand synthesis.

3.5 DNA MICROARRAYS
The custom Escherichia coli DNA microarrays (12 arrays per slide x 135K probes
per array) with probes (45-60mer, 10 probes per target, 3 copies of each probe on array)
for 4,281 E. coli genes and probes for mGFP, TVP1, ampicillin resistance gene (Ampr),
and CAT were prepared by Roche NimbleGen. The DNA microarrays were processed at
Florida State University’s NimbleGen Certified Microarray Facility in Tallahassee,
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Florida. NimbleGen’s NimbleScan software normalizes the gene expression levels with a
quantile normalization method in order to reduce obscuring variation between samples.
The software uses a Robust Multichip Average (RMA) algorithm to generate Calls files
(_RMA.calls) that contain normalized average gene expression values.
The DNA microarray data was imported into ArrayStar™ from the RMA.call
files. Technical replicate expression levels were scaled using the “global averaging” data
transformation. An ANOVA test (p ≤ 0.10) was conducted on the gene expression values
for all of the culture conditions analyzed. A total of 14 sets of biological triplicates (i.e.,
three biological replicates) and one set of six biological replicates (Time 0 of the
VP1GFP ethanol-treated culture) were analyzed. Tukey’s W post-hoc testing (p ≤ 0.05)
and regression analysis (p ≤ 0.05) were subsequently applied to identify genes with
significant differences between these conditions.
Gene annotations were obtained from the ASAP database of the University of
Wisconsin-Madison on January 5, 2013 for Escherichia coli MG1655 Version m56
(Glasner et al. 2003). For genes annotated with unknown products or function (i.e., genes
labeled predicted, putative, or conserved), EcoCyc (Version 16.5) was used (accessed
January 7, 2013) to provide additional information about the gene product or function.
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CHAPTER FOUR
RESULTS AND DISCUSSION

4.1 CELL GROWTH AND PROTEIN PRODUCTION
E. coli MG1655 pTVP1GFP and pGFPCAT were cultured in synchronized shake
flasks to produce either the insoluble VP1GFP or the soluble GFPCAT proteins,
respectively. Overnight cultures were synchronized to an OD of approximately 0.1 at
600 nm, where 1 OD is equivalent to 0.50 g dry cell weight per L. One set of VP1GFP
and GFPCAT cultures was induced with IPTG, while parallel control cultures were not
induced (uninduced). Cultures were induced in the mid-exponential phase (OD of 0.5)
with 1 mM IPTG. Additionally, VP1GFP cultures treated with ethanol were examined
for both induced and uninduced conditions. Samples taken for DNA microarray analysis
were VP1GFP and GFPCAT induced cultures 5, 20, 40, and 60 minutes post-induction,
VP1GFP and GFPCAT uninduced cultures at 0 and 60 minutes relative to the induced
cultures, VP1GFP ethanol-treated uninduced cultures at 0 and 60 minutes, and VP1GFP
ethanol-treated induced cultures at 60 minutes post-induction; in all, 15 conditions with at
least 3 biological replicates were analyzed by DNA microarrays (48 total arrays). The
cell density profiles for the triplicate cultures are shown in Figure 4.1A. The addition of
IPTG did not change the observed growth rate for any of the cultures, as shown by the
lines which represent exponential growth rates of 0.55 h-1 and 0.45 h-1 for
VP1GFP/GFPCAT and ethanol-treated VP1GFP, respectively. For the ethanol-treated
VP1GFP cultures, the growth rate was lower due to the ethanol addition; however, the
IPTG addition did not further alter the growth rate.
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Figure 4.1: Growth and protein expression profiles for E. coli pTVP1GFP and
pGFPCAT. A) Cells were cultured in minimal medium with and without induction and
with and without ethanol treatment. VP1GFP (●, ○), GFPCAT (▲,), and ethanoltreated VP1GFP (♦, ◊). Uninduced (○, , ◊) and Induced (●, ▲, ♦). B) Fluorescent
profiles for E. coli VP1GFP (,●,) and ethanol-treated E. coli VP1GFP (♦,, )
cultures induced at Time 0 hours. Triplicate data are shown. C) Specific CAT activity
profiles for E. coli GFPCAT Uninduced () and Induced (▲) cultures.
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Flow cytometry was used to confirm GFP expression due to IPTG-induction in
both the untreated and the ethanol-treated VP1GFP cultures. As shown in Figure 4.1B,
fluorescent intensity increased linearly post-induction in both untreated and ethanoltreated VP1GFP cultures (p ≤ 0.05); triplicate culture data is shown. Also, the
fluorescent intensity for the ethanol-treated induced cultures was higher than the
untreated induced cultures. Since the addition of 3% ethanol to the VP1GFP protein does
not change the fluorescent intensity, these data indicate that either more VP1GFP was
being expressed or a higher fraction of soluble VP1GFP was being expressed in the cells.
Previous researchers have also suggested the fraction of soluble protein is increased by
ethanol (Thomas and Baneyx 1997). García-Fruitós correlated higher fluorescence
intensity to more soluble protein VP1GFP (García-Fruitós et al. 2005)
GFPCAT expression was quantified via the CAT enzyme assay (Rodriguez and
Tait 1983). Figure 4.1C shows the CAT enzyme assay results for both induced and
uninduced cultures. The specific CAT activity of the uninduced cultures was
approximately 34 U/mg (as expected) (Sharma et al. 2007). The induced culture had a
linear increase in specific CAT activity over 4 hours post-induction (p ≤ 0.05). At 4
hours post-induction, the specific CAT activity of the induced GFPCAT culture was
approximately 23-fold higher than that of the uninduced cultures, which is very
consistent with CAT activity observed for non-fused GFPCAT fusions (Sharma et al.
2007b). Additionally, induced GFPCAT cultures displayed significant growth on 0.61
mM chloramphenicol minimal media plates. Therefore, the GFP did not appear to
significantly alter CAT activity. The fold increase was also observed to be approximately
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23-fold for the induced VP1GFP cultures (Figure 4.1B), whereas the ethanol-treated
VP1GFP induced cultures had approximately 35-fold higher fluorescence intensity than
the ethanol-treated VP1GFP uninduced cultures at 4 hours post-induction. Thus, the
relative induction of the VP1GFP and GFPCAT, both of which were controlled by a trc
promoter, were similar.

4.2 GENE EXPRESSION ANALYSIS
An ANOVA analysis (p ≤ 0.10) of all culture conditions and time points was used
to identify 961 genes with significant differences between at least two conditions.
Tukey’s W post-hoc pairwise comparisons were used to identify genes that had
differential expression between all Time 0 and Time 60 pairings. Results of the pairwise
comparisons are shown below in Table 4.1. Many of the pairwise comparisons were not
biologically meaningful, such as the comparisons between GFPCAT uninduced cultures
and ethanol-treated VP1GFP induced cultures. These types of comparisons are indicated
with an “X” following the number of differentially expressed genes. Additionally, some
of the pairwise comparisons had more than one condition difference (i.e., confounding
effects). For example, the induced VP1GFP 60-minute cultures compared to the
uninduced ethanol-treated VP1GFP cultures. These comparisons are indicated with a
“C” following the number of differentially expressed genes. Four comparisons captured
differentially expressed genes that may be attributed to the solubility state of the
recombinant protein. These four comparisons included: 1) 0-minute to 60-minute for the
induced VP1GFP cultures; 2) uninduced to induced for the VP1GFP 60-minute cultures;
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3) VP1GFP to GFPCAT for the induced 60-minute cultures; and 4) ethanol-treated to
untreated for the induced VP1GFP 60-minute cultures. These four comparisons are
identified in Table 4.1 by bold-faced numbers. Additionally, since the E. coli response to
insoluble recombinant protein is similar to the heat-shock response, the numbers of heatshock genes identified as differentially expressed for the four comparisons are also noted
in Table 4.1.
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Since a key objective of this study was to identify the dynamic transcriptional
events related to IB formation, regression analysis (p ≤ 0.05) was used to identify genes
with time-dependent behavior. The 0-, 5-, 20-, 40- and 60-minute samples were analyzed
for both the VP1GFP and GFPCAT cultures, where the 0-minute samples were taken just
prior to IPTG addition. The regression analysis identified 33 genes with time-dependent
behavior for the VP1GFP cultures and 92 genes with time-dependent behavior for the
GFPCAT cultures. The uninduced VP1GFP and GFPCAT and the uninduced and
induced ethanol-treated cultures did not have a sufficient number of time points to
perform regression analysis. In order to identify a comprehensive set of genes that were
affected by recombinant protein solubility, a union of the four Tukey-identified and the
two regression-identified, time-dependent gene sets was compiled. This union identified
a total of 318 differentially expressed genes. In Table A.1 (Appendix A), all of the 318
differentially expressed genes are listed alphabetically by gene name with fold changes
for the four Tukey comparisons (p ≤ 0.05) and with the slope direction (positive or
negative) for genes with significant regression results (p ≤ 0.05).

4.3 GENE BEHAVIOR—HEAT-SHOCK GENES
In wild-type E. coli, there are 35 classical heat-shock genes that are known to be
up-regulated in response to elevated culture temperatures (clpABPX, dnaJK, gapA,
groLS, grpE, hflB, hscA, hslJRUV, htgA, htpGX, htrABCE, ibpAB, ldhA, lon, lysU, pspA,
rfaD, rlmE, rpoDEH, yrfI) (Gross 1996; Richmond et al. 1999). Many of these heatshock genes are also known to be up-regulated in the presence of misfolded recombinant
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proteins (clpBP, dnaJK, groLS, grpE, hslRUV, htpGX, ibpAB, lon, rlmE, rpoD, yrfI)
(Harcum and Haddadin 2006; Lesley et al. 2002; Smith 2007). The ANOVA analysis (p
≤ 0.10) identified 18 heat-shock genes as significantly regulated, and 14 of these 18 heatshock genes were identified by the union of the Tukey’s W and regression analyses. All
18 significantly regulated classical heat-shock genes (ANOVA p ≤ 0.10) are listed in
Table 4.2 with statistically significant (p ≤0.05) fold changes and regression slope
directions.
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This study identified the same heat-shock genes that Lesley et al. (2002) and
Smith (2007) observed in cells expressing IBs, except the response magnitudes observed
in both of those studies were significantly higher. Table 4.2 lists the fold changes of
classical heat-shock genes in response to IB stress observed in the current study, as well
as fold changes observed in Lesley et al. (2002) and Smith (2002). The fold changes
observed by Lesley et al. (2002) and Smith (2007) for the heat-shock genes were between
2- to 40-fold higher due to insoluble recombinant protein expression; however, in the
current study, fold changes wer only between 1.5- to 2.2. Several factors likely
contributed to these differences: 1) In this study, a minimal medium was used to slow
growth rates to 0.55 h-1, whereas the LB medium used by Lesley et al. (2002) and Smith
(2007) commonly has growth rates of approximately 2.0 h-1; 2) Lesley et al. (2002) used
6x His-tags on all proteins, whereas in this study, only GFPCAT had a 6x His-tag; 3)
Smith (2007) expressed recombinant proteins in E. coli BL21, whereas in this study, E.
coli K-12 strain was used as the host; and 4) Both Lesley et al. (2002) and Smith (2007)
used strong T7-based promoters, whereas in this study, the weaker trc promoter was
used. The significantly higher growth rates in LB medium compared to a minimal
medium would allow for more cell doublings within 60 minutes, and thus, the turnover
rates for mRNA species would be higher, allowing for more accumulation to be
observed. Despite the magnitude difference in the heat-shock responses, the present
study identified the same heat-shock genes as Lesley et al. (2002) and Smith (2007).
Thus, the dynamic behavior obtained by this study for heat-shock and other differentially
expressed genes will be representative of insoluble protein effects but with much lower
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magnitudes. Additionally, the dynamic behavior has not previously been reported
(Lesley et al. 2002; Smith 2007).
In order to better understand the time-dynamic behavior of the heat-shock genes,
time profiles for each of the 14 differentially expressed heat-shock genes was examined
for the VP1GFP and GFPCAT cultures (Figure 4.2). Additionally, the time profiles for
tig, the trigger factor that constitutes one of the three major protein folding chaperones in
E. coli (along with dnaK and groLS), were included. The heat-shock genes identified by
the regression analysis with positive slopes for VP1GFP are shown in the first two rows
(clpB, dnaK, gapA, groLS, htpG). The time profiles of these six genes indicate that these
genes responded early to the synthesis of VP1GFP, whereas the other heat-shock genes
responded later, between 40 and 60 minutes post-induction, and seemed to be responding
more to the presence of VP1GFP than to the synthesis of VP1GFP. Specifically, the
chaperone genes responded immediately to the synthesis of VP1GFP with a linear
increase in expression. In contrast, the protease genes responded later in time, after the
insoluble VP1GFP protein had begun to accumulate within the cells.
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Figure 4.2: Classical Heat Shock and tig gene expression profiles. The dynamic gene
expression profiles for E. coli VP1GFP and GFPCAT heat-shock genes and the proteinfolding chaperone gene tig. VP1GFP (,□), GFPCAT (▲,), and ethanol-treated
VP1GFP (♦, ◊); Uninduced (□, , ◊) and Induced (, ▲, ♦) are shown. Gene expression
levels were normalized to 100, which represents the “average” gene expression intensity
on the DNA microarray. Standard error bars are shown.
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Within the DnaK-DnaJ-GrpE chaperone system, also known as the Hsp70
chaperone system, dnaJ, a protein folding chaperone gene, was not identified by
regression analysis on VP1GFP cultures and instead displayed a delayed response similar
to the heat-shock proteases, while grpE was not identified to have statistically significant
behavior. The dnaK gene expression level immediately increased due to VP1GFP
synthesis. These behavior differences are expected mechanistically. The Hsp70
chaperone system is powered by ATPase activity and is always in an ATP-bound state or
an ADP-bound state. In the ATP-bound state, the substrate-binding pocket is open and
allows for binding of misfolded protein domains, while in the ADP-bound state, the
substrate binding pocket is closed and allows for the chaperone to interact with and fold a
misfolded protein. Hydrolysis of ATP is usually the rate-limiting step for the Hsp70
chaperone system, and DnaK provides the primary ATPase activity for the Hsp70
chaperone system (Bukau and Horwich 1998, Keseler et al 2012). Thus, it is expected
that dnaK would be up-regulated in response to misfolded protein prior to dnaJ and grpE.
In addition to the heat-shock genes, an additional 30 genes regulated by the heatshock transcription factor rpoH, or σ32, were included in the 318 differentially expressed
genes (aaeB, dcuR, entD, hcaR, kdgR, lexA, lrp, lspA, lysR, mlrA, nadR, nhaR, nor,
phoQ, proB, rcnR, rhaR, rsmI, sdiA, yaiO, ybeX, ybeZ, ydeO, yeeJ, yfiR, yghQ, yjfP, yjfZ,
yqeG, yqjF). The rpoH gene was not significantly changed due to IBs, which is
consistent with previous observations (Harcum and Haddadin 2006; Lesley et al. 2002;
Smith 2007). Recombinant protein overexpression and insolubility cause similar, but not
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identical, responses to heat stress. Also, the recombinant cultures in this study were not
exposed to elevated temperatures

4.4 GENE BEHAVIOR—GENE ONTOLOGIES
In order to identify gene functions that were sensitive to IBs, the 318 genes with
differential expression were grouped by common functionalities using gene ontology
(GO) terms from the ASAP database and EcoCyc. Most genes had several GO term
entries. In those cases, the dominant function of the encoded protein was used for
classification so that no single gene is represented twice. For example, lon is listed with
13 GO terms, ranging from “response to stress” to “DNA-binding.” The protein product
of lon is the protease La, which is a well-characterized protease in E. coli that degrades
abnormal proteins. Thus, lon was grouped under Proteolysis. Figure 4.3 shows the gene
classifications, with the number of genes with a particular GO term indicated. Table A.2
(Appendix A) lists all genes grouped by classification. For the 14 differentially
expressed heat-shock genes, eight genes were grouped with Protein Folding (clpB,
dnaJK, groLS, hslUV, and htpG), four genes were grouped with Proteolysis (clpP, ftsH,
htpX, and lon), one gene was grouped with Energy Metabolism (gapA, a glyceraldehyde3-phosphate dehydrogenase involved in glycolysis), and one gene was grouped with
RNA Methylation (rlmE, a 23S rRNA methyltransferase).
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For the 318 genes with differential expression, the largest fraction of genes was
classified within Metabolic Process (152 genes), as shown in Figure 4.3. The metabolic
process group contained the following sub-classifications (with number of genes
indicated in parentheses): Biosynthesis (38 genes), RNA Metabolism (33 genes),
Catabolism (26 genes), Energy Metabolism (23 genes), Protein Metabolism (16 genes),
and DNA Metabolism (5 genes); and eleven metabolic process genes did not align with
these sub-classifications (aphA, deoA, frc, glpK, guaD, hyuA, pntA, pps, sufS, yicI, and
yihQ). After metabolic process, Putative genes were the next largest first-level
classification (111 genes), representing 35% of the differentially expressed genes. Since
only approximately 14% of the E. coli genome is considered to be of unknown function
(Riley et al. 2006), this high proportion of putative genes indicates that E. coli responds
to insoluble recombinant proteins using many genes that have not been well-studied. The
remaining first-level classifications were Transmembrane Transport (33 genes) and
Transcription Regulation (17 genes). Of the 318 differentially expressed genes, five
genes did not align with these classifications (asr, fimFG, tsr, yeeJ), and were mainly cell
wall components. These gene classifications were subsequently used to identify
coordinated behavior within cellular functionalities due to insoluble recombinant protein
expression (IB formation).

Protein Metabolism
Protein metabolism genes encode for chaperones that assist with protein synthesis
and proteases that degrade misfolded or unneeded proteins. Within the protein
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metabolism group, nine protein folding and seven proteolysis genes were identified. The
nine protein folding genes include eight classical heat-shock genes (clpB, dnaJK, groLS,
hslUV, and htpG), plus tig. All of the protein-folding genes increased in expression due
to VP1GFP production, including tig. The time profile for tig is shown in Figure 4.2
with the classical heat-shock genes; although tig is not a classical heat-shock protein, it is
a chaperone. The observed behavior of the tig gene, however, was more similar to the
heat-shock protease genes (clpP, ftsH, htpX, and lon) as opposed to the heat-shock
folding chaperone genes (i.e., tig expression did not increase immediately due to
VP1GFP production). The seven proteolysis genes identified included four classical
heat-shock genes (clpP, ftsH, htpX, and lon), plus ompX and pepBN. The ompX and
pepBN gene time profiles are very similar to the heat-shock protease genes, indicating
that the accumulation of insoluble recombinant protein increases protease gene
expression more so than the initial production of insoluble recombinant protein.

Protein Synthesis-Related Gene Classifications
Many of the differentially expressed genes were involved with protein synthesis,
including genes involved with ribosomal subunits (rplACEJLNQR, rpmDIJ, and
rpsAFGHLMNPU), aminoacyl-tRNA synthetases (asnS, leuS, pheT, thrS, and tyrS), and
amino acid synthesis (aroAG, dadX, gdhA, hisGH, lrp, metH, proB, thrC, and trpCD).
These genes are shown in Table 4.3 with gene ontologies. The most coordinated group
was the ribosomal subunit genes. Twenty ribosomal subunit genes were identified,
including both 30S ribosomal subunit genes (rpsAFGHLMNPU) and 50S ribosomal
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subunit genes (rplACEJLNQR and rpmDIJ). The behavior of these 20 genes was very
similar within cultures (Figure 4.4ABC). Thus, average time profiles represent well the
dynamic behavior of a coordinated gene group (Figure 4.4D). The average time profiles
for the ribosomal subunit genes are also shown in Figure 4.5A with the other proteinsynthesis-related genes. There are 55 ribosomal subunit genes in E. coli; however, the
remaining 35 ribosomal subunit genes did not meet statistical significance, although the
time profiles were very similar to the 20 ribosomal subunit genes that were identified
(Figure B.1 in Appendix B). The ribosomal subunit gene expression levels increased
due to protein expression: soluble GFPCAT expression resulted in a linear increase in
expression; VP1GFP expression initially resulted in a similar linear increase, but between
40 and 60 minutes post-induction, a dramatic increase was observed. Interestingly, the
ribosomal subunit gene expression profiles of the ethanol-treated VP1GFP cultures
resembled the time profiles of the GFPCAT cultures more so than the time profiles of the
untreated VP1GFP cultures, indicating that ethanol dampened the ribosomal subunit
response to the high level of VP1GFP synthesis and to the presence of VP1GFP, as the
ethanol-treated VP1GFP cell contained very high levels of VP1GFP (see Figure 4.1B).
Past studies have indicated that the expression of ribosomal proteins and other protein
synthesis machinery can be down-regulated in high-expression recombinant protein
systems, presumably due to aminoacyl-tRNA deprivation (Dong et al. 1995; Gallant
1979; Rinas 2008). The seemingly contradictory results of this study may indicate that
cells grown in minimal medium and analyzed predominantly in the early-phases of
recombinant protein production (≤ 1 hour post-induction) had not yet encountered a
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significant shortage of amino acids or charged tRNAs. Interestingly, the addition of
ethanol decreased the expression of the ribosomal subunit genes, and the ribosomal
subunit expression remained lower after induction. Ethanol decreased cell growth, a
characteristic consistent with past studies (Thomas and Baneyx 1997), where inhibited
cell growth is consistent with a decrease in overall protein synthesis (Figure 4.1A).
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Figure 4.4: Time profiles for ribosomal subunit genes. The individual gene time
profiles for 20 differentially expressed ribosomal subunit genes are shown for the A)
VP1GFP, B) GFPCAT, and C) Ethanol-treated VP1GFP cultures. The average time
profiles for all 20 differentially expressed ribosomal subunit genes are shown by culture
(D). VP1GFP (,□), GFPCAT (▲,), and ethanol-treated VP1GFP (♦, ◊); Uninduced
(□, , ◊) and Induced (, ▲, ♦) are shown. Gene expression levels were normalized to
100, which represents the “average” gene expression intensity on the DNA microarray.
Standard error bars are shown.
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Figure 4.5: Gene expression profiles for protein synthesis-related genes with differential expression for E. coli
pTVP1GFP and pGFPCAT. A) Ribosomal subunit genes (average of 20 genes). B) Aminoacyl-tRNA Synthetase genes
(average of 5 genes). C) Amino Acid Synthesis genes (average of 12 genes). VP1GFP (,□), GFPCAT (▲,), and ethanoltreated VP1GFP (♦, ◊); Uninduced (□, , ◊) and Induced (, ▲, ♦) are shown. Gene expression levels were normalized to
100, which represents the “average” gene expression intensity on the DNA microarray. Standard error bars are shown
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The ribosomal subunit gene expression levels were relatively high at Time 0 in
VP1GFP cultures relative to ethanol-treated VP1GFP and GFPCAT cultures. By
examining the raw data by biological replicate, it was determined that biological replicate
B was particularly high for many genes, even when normalized to the average gene on
the DNA microarray. For example, the ribosomal subunit gene expression levels are
shown for replicates A, B, and C for VP1GFP Time 0 in Figure 4.6. An ANOVA test
with Bonferroni multiple testing was used on the three biological replicates of VP1GFP;
however, the number of differentially expressed genes was not greater than the false
positive rate. Thus, there was not enough statistical evidence to warrant exclusion of any
replicates of VP1GFP Time 0, and replicate B was utilized for all data analysis.
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Figure 4.6: Gene expression levels of ribosomal subunit genes across biological
replicates. Data for three biological replicates of VP1GFP Time 0 cultures are shown.
Gene expression levels were normalized to 100, which represents the “average” gene
expression intensity on the DNA microarray. The error bars represent 95% confidence
intervals.
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Amino acid synthesis genes (aroAG, dadX, gdhA, hisGH, lrp, metH, proB, thrC,
trpCD) encode for enzymes involved in the various pathways used to generate amino
acids. The amino acid synthesis genes shown in Figure 4.5B had similar expression
profiles to the ribosomal subunit genes shown in Figure 4.5A. The amino acid synthesis
gene expression levels increased due to protein expression for both the soluble and
insoluble proteins, but were increased to a greater extent by VP1GFP expression. The
similar responses of the ribosomal subunit genes and amino acid synthesis genes support
the observed increase in protein synthesis machinery levels in response to recombinant
protein expression.
Aminoacyl-tRNA synthetase genes encode for the enzymes responsible for
covalently binding amino acids to tRNA molecules for protein synthesis (i.e., aminoacyltRNA charging). For the aminoacyl-tRNA synthetase genes identified in this study as
differentially expressed (asnS, leuS, pheT, thrS, and tyrS), the most pronounced increase
in expression was observed for induced VP1GFP 60-minute cultures post-induction.
Time profiles for aminoacyl-tRNA synthetase genes are shown in Figure 4.5C and are
very similar to the heat-shock proteases. The observed delay in increased expression may
indicate that the aminoacyl-tRNA synthetase genes responded to the accumulation of
VP1GFP more so than to the initial synthesis of VP1GFP.
Lesley et al. (2002) and Smith (2007) did not observe coordinated changes in the
expression for the amino acid synthesis or aminoacyl-tRNA synthetase genes in response
to insoluble recombinant protein (Lesley et al. 2002; Smith 2007). These previous
studies were conducted in LB medium, which provides high levels of amino acids to the
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cells. In contrast, growth in minimal medium requires the cells to synthesize all amino
acids from glucose and ammonium. The observed increased expression of the ribosomal
subunit, amino acid synthesis, and aminoacyl-tRNA synthetase genes in this study
indicates that the cells were adapting to increased protein synthesis rates for both
VP1GFP and GFPCAT cultures; however, the response was greater for the VP1GFP
cultures, indicating there may be a solubility related response too.

Transmembrane Transport
Transmembrane transport genes encode for proteins that control cellular import
and export of medium components. In the current study, 33 transmembrane transport
genes were identified as having differential expression. Within these 33 transmembrane
transport genes, 13 carbohydrate transport genes (actP, bglF, dgoT, fucP, glpF, gntT,
lamB, malF, opgH, ugpAB, uhpT, and ulaA) and eight amino acid transport genes
(dppBC, dtpB, eamB, gltS, gspDL, and tdcC) were identified, as well as 12
transmembrane transport genes that were not further sub-classified (aaeB, acrBF, blc,
btuE, cysP, lspA, modB, ompF, pstS, purP, and tsgA). Eleven carbohydrate transport
genes, six amino acid transport genes, and six of the unclassified genes decreased
significantly due to VP1GFP production, whereas these effects were not observed in the
ethanol-treated VP1GFP and GFPCAT cultures. These 23 genes are listed in Table 4.4.
The average time profiles for these 23 transmembrane transport genes with decreased
expression due to VP1GFP production are shown in Figure 4.7A. The dynamic response
of these time profiles indicates that the transporter genes appeared to be affected by
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VP1GFP synthesis initially and further by the accumulation of VP1GFP. Lesley et al.
(2002) and Smith (2007) also noted the decreased expression of several membrane
transporters due to the presence of insoluble recombinant protein, including various sugar
and metal ion transporters (chaA, fecB, feoA, fruA, glpF, lamB, rbsC, setA, ychM) (Lesley
et al. 2002; Smith 2007). This study identified the decreased expression of several
transporters previously not associated with IBs (aaeB, acrFP, bglF, blc, dgoT, dtpB,
eamB, fucP, gltS, gntT, gspDL, malF, modB, purP, tdcC, tsgA, ugpB, uhpT, ulaA).
Interestingly, for the 23 transmembrane transporters that had decreased expression due to
the presence of VP1GFP, 13 genes are directly regulated by the cyclic AMP receptor
protein, Crp, (including 10 of the 11 carbohydrate transport genes). These 13 genes are
indicated in Table 4.4. The Crp protein is known to regulate catabolite repression, or the
preferential utilization of certain carbon sources over others (Görke and Stülke 2008;
Gosset et al. 2004). The Crp-controlled genes that decreased in expression facilitated
entry of a variety of substrates, such as actP (glycolate), bglF (methyl-β-D-glucoside-6phosphate and arbutin-6-phosphate), dgoT (galactonate), fucP (fucose), glpF (glycerol),
gntT (gluconate), lamB/malF (β-maltose), and uhpT (hexose phosphate); however, in this
study, glucose was the sole carbon source. Thus, the decreased expression of these Crpcontrolled transporters may indicate that VP1GFP production shifts metabolic efforts
onto specific substrates by down-regulating unnecessary transporter proteins or that IB
stress induces a physical change at the cellular membrane.
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Figure 4.7: Gene expression profiles for transmembrane transport and catabolism
genes with differential expression for E. coli pTVP1GFP and pGFPCAT. A)
Transmembrane transport genes with decreased expression due to VP1GFP (average of
23 genes). B) Catabolism genes with decreased expression due to VP1GFP (average of
19 genes). VP1GFP (,□), GFPCAT (▲,), and ethanol-treated VP1GFP (♦, ◊);
Uninduced (□, , ◊) and Induced (, ▲, ♦) are shown. Gene expression levels were
normalized to 100, which represents the “average” gene expression intensity on the DNA
microarray. Standard error bars are shown
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Catabolism
Catabolism reactions in cells control the breakdown and recycling of cellular
building blocks. The catabolism classification mainly identified carbohydrate and amino
acid degradation genes with differential expression. For carbohydrate degradation, 12 of
the 13 genes identified decreased due to VP1GFP expression (bglB, dgoDK, glcD, gudD,
maoC, mtlD, rhaBM, treF, uxuB, and yiaS). Additionally, three amino acid degradation
genes (dtd, tdh, and tnaA) and four unclassified catabolism genes (caiB, chiA, cpdB, and
nudE) decreased due to VP1GFP expression. These 19 catabolic genes are listed in
Table 4.5, and the average time profiles for these 19 genes are shown in Figure 4.7B.
These catabolism genes had time profiles similar to the transmembrane transport genes;
genes appeared to be affected by VP1GFP synthesis initially and further by the
accumulation of VP1GFP.
For the 19 transmembrane transporters that had decreased expression due to the
presence of VP1GFP, 9 genes are directly regulated by Crp. These 9 genes are indicated
in Table 4.5. Taken in conjunction with the coordinated decrease in expression of Crpcontrolled transmembrane transport genes, these results seem to indicate that catabolite
repression may have been occurring in the cells. Interestingly, several of transmembrane
transporter genes with decreased expression due to VP1GFP acted upon the same target
substrate as many catabolic genes with decreased expression due to VP1GFP. For
example, the dgoT gene encodes the D-galactonate transporter and the dgoDK genes
encode enzymes that degrade D-galactonate (Karp et al. 2010). Table 4.6 lists the
catabolic genes and transmembrane transporter genes with identical target substrates.
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These catabolic and transnmembrane transporter genes all had decreased expression due
to VP1GFP production but were all unaffected by GFPCAT production and by VP1GFP
production in the ethanol-treated cultures. Lesley (2002) and Smith (2007) did not
observe coordinated expression between catabolism genes and transmembrane transporter
genes. These results indicate that cells respond to the onset of IB stress through a
coordinated down-regulation of transporters and metabolic degraders of a variety of
substrates and that the cells may be undergoing catabolite repression to a degree.
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Table 4.6: Transmembrane transporters and catabolic genes with common
substrates. These genes had decreased expression due to VP1GFP production. The
connections were determined by the PathwayTools software Version 13.0 (Karp et al.
2010).
Transmembrane
Transport Gene with
Decreased Expression Due
to VP1GFP Production

Gene in Catabolic
Pathway with Decreased
Expression Due to
VP1GFP Production

D-galactonate

dgoT

dgoDK

Glycolate

actP

glcD

Arbutin-6-phosphate
Methyl-β-D-glucoside-6phosphate

bglF

bglB

bglF

bglB

Threonine

tdcC

tdh

Cysteine

eamB

tnaA

Substrate
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Cofactor Synthesis
Cofactors are compounds required by a protein to function properly and often
modulate enzyme activity. Within the cofactor synthesis gene classification, nine genes
increased in expression level due to VP1GFP synthesis, whereas these effects were not
observed in the ethanol-treated VP1GFP and GFPCAT cultures (dxs, folC, hemL,
ispEFG, and thiCMS). These nine genes are listed in Table 4.7, and the time profiles are
shown in Figure B.2 (Appendix B). The dxs and ispEFG genes encode enzymes in the
methylerythritol phosphate pathway, which primarily synthesizes membrane glycolipids,
peptidoglycans, and quinols. Taken in conjunction with the regulation of many
transmembrane transporters, the increased expression of the dxs and ispEFG genes may
indicate that VP1GFP accumulation induces a physical change of the cell membrane and
that the cells were attempting to repair or reinforce the cell membrane. The thiCMS
genes encode enzymes involved in thiamine diphosphate synthesis, an essential cofactor
for both pyruvate dehydrogenase and transketolase. Pyruvate dehydrogenase is involved
with decarboxylating pyruvate into acetyl-CoA in order to feed the TCA cycle.
Transketolase is involved with catabolizing sugars in the pentose phosphate pathway.
Thus, the increased expression of the thiCMS genes may indicate that cells were
attempting to increase energy production in response to VP1GFP accumulation.
Interestingly, the genes encoding for pyruvate dehydrogenase (aceEF and lpd) and
transketolase (tktA) were not identified statistically as differentially expressed but had
time profiles that were similar to the time profiles of thiCMS and the other identified
cofactor synthesis genes (Figure B.3 in Appendix B). Overall, these nine cofactor
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synthesis genes had time profiles similar to the time profiles of the heat-shock proteases
shown in Figure 4.2, indicating that these genes are sensitive to VP1GFP accumulation
more so than to the initial synthesis of VP1GFP.
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Table 4.7: Cofactor synthesis genes with increased expression levels due to IB stress.
Cofactor synthesis genes that were identified for increased expression due to VP1GFP
accumulation. The regression analysis slopes (p ≤ 0.05) are indicated (+/-;
positive/negative slopes). Fold changes for Tukey’s W pairwise comparisons (p ≤ 0.05)
are indicated. [For fold changes, A = VP1GFP 60-minute induced vs. VP1GFP 0-minute
uninduced. B = VP1GFP 60-minute induced vs. VP1GFP 60-minute uninduced. C =
VP1GFP 60-minute induced vs. GFPCAT 60-minute induced.]

Regression
Slope
VP1GFPGFP
CAT

bname

Gene

Product

b0420

dxs

b2315

folC

b0154

hemL

b1208

ispE

b2746

ispF

b2515

ispG

b3994

thiC

b2104

thiM

1-deoxyxylulose-5-phosphate synthase,
thiamine-requiring, FAD-requiring
bifunctional folylpolyglutamate
synthase/dihydrofolate synthase
glutamate-1-semialdehyde
aminotransferase (aminomutase)
4-diphosphocytidyl-2-C-methylerythritol
kinase
2C-methyl-D-erythritol 2,4cyclodiphosphate synthase
1-hydroxy-2-methyl-2-(E)-butenyl 4diphosphate synthase
thiamin (pyrimidine moiety) biosynthesis
protein
hydoxyethylthiazole kinase

b4407

thiS

sulfur carrier protein

A

B

C
1.1
1.1
1.3

1.3
1.2
1.4
1.4
1.2
-
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Fold Changes

Energy Metabolism
Energy metabolism genes are responsible for extracting metabolic energy (usually
in the form of ATP, NADH, or quinols) from carbon sources, such as glucose. In this
study, 23 energy metabolism genes were identified as significantly changed. Six TCA
cycle genes had increased expression levels due to both VP1GFP and GFPCAT synthesis
(acnB, gltA, sdhAB, and sucBC), but were increased to a greater extent by VP1GFP
expression. Ethanol treatment reduced the magnitude of the increase of these six TCA
cycle genes. These six TCA cycle genes are listed below in Table 4.8, and the time
profiles for these six TCA cycle genes are shown in Figure 4.8. Additionally, 12 other
TCA cycle genes (acnA, fumABC, icd, lpd, mdh, mqo, sdhCD, and sucAD) that did not
meet statistical significance had time profiles similar to the six identified TCA cycle
genes (Figure B.4 in Appendix B). The coordinated increased expression of the TCA
cycle genes supports previous observations that protein synthesis is an energy intensive
process (Glick 1995); however, insoluble VP1GFP protein accumulation creates a greater
need for energy that is mitigated by the addition of ethanol.
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Table 4.8: TCA cycle genes with differential expression. TCA cycle genes that were
identified as differentially expressed. The regression analysis slopes (p ≤ 0.05) are
indicated (+/-; positive/negative slopes). Fold changes for Tukey’s W pairwise
comparisons (p ≤ 0.05) are indicated. [For fold changes, A = VP1GFP 60-minute
induced vs. VP1GFP 0-minute uninduced. B = VP1GFP 60-minute induced vs. VP1GFP
60-minute uninduced. C = VP1GFP 60-minute induced vs. GFPCAT 60-minute induced.]
Regression
Slope
VP1- GFPGFP CAT

bname

Gene

Product

b0118

acnB

bifunctional aconitate hydratase 2/2methylisocitrate dehydratase

b0720

gltA

citrate synthase

b0723

sdhA

succinate dehydrogenase, flavoprotein
subunit

b0724
b0727
b0728

sdhB
sucB
sucC

succinate dehydrogenase, FeS subunit
dihydrolipoyltranssuccinase
succinyl-CoA synthetase, beta subunit

Fold Changes
A

B
1.3

+
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1.4
1.2
+
+

C

Figure 4.8: Gene expression profiles for TCA cycle genes with differential
expression for E. coli pTVP1GFP and pGFPCAT. A) TCA Cycle (average of 6
genes). VP1GFP (,□), GFPCAT (▲,), and ethanol-treated VP1GFP (♦, ◊);
Uninduced (□, , ◊) and Induced (, ▲, ♦) are shown. Gene expression levels were
normalized to 100, which represents the “average” gene expression intensity on the DNA
microarray. Standard error bars are shown.
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In addition to the TCA cycle genes, two ATP synthase genes (atpFI) were
observed to have differential expression due to GFPCAT and VP1GFP expression. The
atpF gene expression profile increased due to both GFPCAT and VP1GFP expression
similar to that observed for the ribosomal subunit genes (Figure B.5 in Appendix B).
The atpF gene encodes for subunit b of the ATP synthase F0 sector, which is critical to
proton translocation. There are seven additional genes that encode for subunits of the
F1F0 ATP synthase complex (atpABCDEGH). The gene expression profiles of these
seven genes were similar to atpF; however, these seven genes did not meet statistical
significance (Figure B.5 in Appendix B). Interestingly, atpI gene is considered to be
unessential for the function of the ATP synthase complex (Keseler et al. 2012) and was
observed to be decreased due to GFPCAT and VP1GFP expression. The increased
expression of ATP synthase genes is consistent with increased cellular ATP needs due to
recombinant protein expression.
Of the remaining energy metabolism genes, eight genes involved in the electron
transport chain were increased due to VP1GFP accumulation (appC, dld, hyaDE, napD,
narW, and nuoCG). These eight genes encode for components of the NADH
oxidoreductase, cytochrome oxidase, nitrate reductase, hydrogenase 1, and lactate
dehydrogenase complexes (Keseler et al. 2012). These eight genes are listed in Table
4.9, and the time profiles are shown in Figure B.6 (Appendix B). The electron transport
chain is a key energy generating pathway, where electron transfer is coupled with
transmembrane proton translocation and results in a proton gradient to produce ATP via
ATP synthase (Weber and Senior 2003). Overall, these eight genes involved with the
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electron transport chain had time profiles similar to the time profiles of the heat-shock
proteases shown in Figure 4.2, indicating that these eight genes are sensitive to VP1GFP
accumulation more so than to the initial synthesis of VP1GFP. Lesley (2002) and Smith
(2007) did not observe coordinated changes in expression for electron transport genes.
Most likely, the multiple carbon sources present in LB medium mitigated this response.
The increased gene expression involved in electron transport processes is consistent with
the higher metabolic burden associated with recombinant protein expression (Glick 1995)
and additionally the energy-intensive processes needed to cope with misfolded proteins
(Bukau and Horwich 1998).
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Table 4.9: Eight genes involved in electron transport chain with increased
expression levels due to IB stress. Genes involved in electron transport chain that were
identified for increased expression due to VP1GFP accumulation. The regression
analysis slopes (p ≤ 0.05) are indicated (+/-; positive/negative slopes). Fold changes for
Tukey’s W pairwise comparisons (p ≤ 0.05) are indicated. [For fold changes, A =
VP1GFP 60-minute induced vs. VP1GFP 0-minute uninduced. B = VP1GFP 60-minute
induced vs. VP1GFP 60-minute uninduced. C = VP1GFP 60-minute induced vs.
GFPCAT 60-minute induced.]

bname

Gene

b0978

appC

b2133

Regression
Slope
VP1- GFPGFP CAT

Product

Fold Changes
A

B

C

cytochrome bd-II oxidase, subunit I

1.6

dld

D-lactate dehydrogenase, FAD-binding,
NADH independent

1.1

b0975

hyaD

protein involved in processing of HyaA
and HyaB proteins

b0976

hyaE

protein involved in processing of HyaA
and HyaB proteins

b2207

napD

assembly protein for periplasmic nitrate
reductase

b1466

narW

nitrate reductase 2 (NRZ), delta subunit
(assembly subunit)

b2286
b2283

NADH:ubiquinone oxidoreductase, chain
C,D
NADH:ubiquinone oxidoreductase, chain
nuoG
G
nuoC
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+

1.2
-

1.4
1.3

+

1.2
1.4
1.5 1.4

Transcription Regulation
Transcription regulation genes control transcription rates. Altered levels of a
transcription regulation gene can have a strong impact on several related cellular
functions. In this study, 17 transcription regulation genes were identified as differentially
expressed. Nine transcription regulation genes were observed to decrease in response to
VP1GFP accumulation (atoS, dcuR, hcaR, lexA, lysR, nadR, rcnR, rfaH, and rhaR), and
one gene (sdiA) was observed to decrease in expression for the VP1GFP cultures relative
to the ethanol-treated VP1GFP cultures. These ten genes with decreased expression due
to VP1GFP production are listed in Table 4.10, and the time profiles are shown in
Figure B.7 in Appendix B. The time profiles for these transcription regulation genes are
similar to the transmembrane transport genes in Figure 4.7A. The differentiialy
expressed transcription regulation genes control several cellular functionalities. The
atoS, hcaR, nadR, and rhaR genes all control various catabolic pathways, including
catabolic pathways for short-chain fatty acids (atoS), rhamnose (rhaR), NADP (nadR),
and hydrocinnamic acid (hcaR). The decreased expression of genes that regulate
catabolic pathways supports the observed decreased gene expression for catabolic
pathways discussed earlier. Addionally, the lexA gene is known to repress genes
involved in DNA repair which are needed for the SOS response; decreased lexA levels
would result in higher DNA repair (Fernández de Henestrosa et al. 2000). The decreased
expression of lexA may indicate that the accumulation of VP1GFP resulted in DNA
damage. Finally, the sdiA gene controls several genes that promote cell division;
decreased sdiA levels would inhibit cell division (García-Lara et al. 1996, Keseler et al.
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2012). The decreased expression of sdiA may be indicative of cells slowing growth in
response to the accumulation of VP1GFP.
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Table 4.10: Transcription regulation genes with decreased expression levels due to
IB stress. Transcription regulation genes that were identified for decreased expression
due to VP1GFP accumulation. The regression analysis slopes (p ≤ 0.05) are indicated
(+/-; positive/negative slopes). Fold changes for Tukey’s W pairwise comparisons (p ≤
0.05) are indicated. [For fold changes, A = VP1GFP 60-minute induced vs. VP1GFP 0minute uninduced. B = VP1GFP 60-minute induced vs. VP1GFP 60-minute uninduced.
C = VP1GFP 60-minute induced vs. GFPCAT 60-minute induced.]

bname Gene
b2219

atoS

b4124

dcuR

b2537

hcaR

b4043

lexA

b2839

lysR

b4390

nadR

b2105

rcnR

b3842

rfaH

b3906

rhaR

b1916

sdiA

Regression
Slope
VP1- GFPGFP
CAT

Product

Fold Changes
A

sensory histidine kinase in twocomponent regulatory system with
AtoC
DNA-binding response regulator in
two-component regulatory system with
DcuS
DNA-binding transcriptional activator
of 3-phenylpropionic acid catabolism

transcriptional repressor of rcnA
DNA-binding transcriptional
antiterminator
DNA-binding transcriptional activator,
L-rhamnose-binding
DNA-binding transcriptional activator
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C

0.8

0.8 0.8
0.8

DNA-binding transcriptional repressor
of SOS regulon
DNA-binding transcriptional dual
regulator
NadR transcriptional repressor /
ribosylnicotinamide kinase / NMN
adenylyltransferase

B

0.9
0.9 0.9
-

0.9

0.9
0.9
0.8
0.8 0.8

Three transcription regulation genes were observed to increase due to VP1GFP
production, but were unaffected by GFPCAT production (kdgR, nusA, and phoQ). The
time profiles for these three genes are similar to the heat-shock proteases (Figure B.8 in
Appendix B). The nusA gene plays a key role in ribosomal RNA synthesis by modifying
RNA polymerase in order to promote effective transcription of 5S, 16S, and 23S rRNA
(Keseler et al 2012, Quan et al 2005). The increased nusA levels may indicate a need for
greater protein synthesis in response to VP1GFP accumulation, which is consistent with
the increased levels of many protein synthesis-related genes also observed in this study
(Tables 4.3 and Figure 4.5ABC). The phoQ gene is known to increase under
magnesium starvation (Kato et al. 1999); thus, the increased phoQ levels may indicate
that the IB stress caused a greater degree of magnesium utilization. This magnesium
starvation may have been brought on by increased protease activity in response to
VP1GFP accumulation; at least two proteases in E. coli are magnesium-dependent, and
both are associated with IB formation. The clpP gene was observed to increase in
expression due to insoluble recombinant protein production in this study and by Lesley et
al. (2002) and Smith (2007); clpP encodes for a magnesium-dependent protease (Gross
1996). Additionally, there is at least one more unindentified magnesium-dependent
protease in E. coli, where protease function decreases under low magnesium
concentration (Jordan and Harcum 2002).
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Effects of Ethanol on IB Stress Response
The effects of ethanol were also analyzed in this study. Since ethanol is known to
improve recombinant protein solubility (Thomas and Baneyx 1997), the stress response
to IBs should theoretically be dampened when cells are grown in ethanol. Surprisingly,
only nine genes were differentially expressed between the untreated and the ethanoltreated VP1GFP cultures, compared to 126 differentially expressed genes between
VP1GFP and GFPCAT cultures. The similar transcriptome profiles between untreated
and ethanol-treated VP1GFP cultures seem to indicate that ethanol did not mitigate IB
stress dramatically. However, by examining the time profiles for genes identified to be
sensitive to VP1GFP production, it is clear that ethanol affects gene expression dynamics
and mitigates many of the responses associated with insoluble protein accumulation.
These results may suggest that ethanol-treated medium relieves IB stress by altering
expression levels of genes related to heat-shock (Figure 4.2), ribosomal subunits
(Figure 4.5A), aminoacyl-tRNA synthetases (Figure 4.5B), transmembrane transporters
(Figure 4.7A), and catabolism genes (Figure 4.7B). Due to the lack of statistical
differences observed between VP1GFP and ethanol-treated VP1GFP gene expression
levels, further research is needed to clarify the effects of ethanol treatment on the stress
responses caused by IB formation.
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CHAPTER FIVE
CONCLUSION

With E. coli, the tendency for recombinant proteins to misfold and form inclusion
bodies (IBs) represents a major roadblock to large-scale production processes. This study
characterized the dynamic transcriptional behavior of E. coli in the early stages of
insoluble recombinant protein production. As expected, classical heat-shock genes had
increased expression due to IB formation. Additionally, several protein-folding and
protease genes not associated with the classical heat-shock response had increased
expression levels due to IB formation. The increased levels for genes involved in
protein-folding and in proteolysis indicates that the cells attempt to alleviate this stress by
increased synthesis of chaperones to assist with protein folding and by increased
synthesis of proteases to remove misfolded proteins.
It was also observed that components of the cellular protein synthesis machinery
had increased expression due to recombinant protein expression but were more severely
affected by IB formation, including ribosomal subunit genes and genes involved with
amino acid synthetic pathways. Additionally, the aminoacyl-tRNA synthetase gene
increased specifically due to IB formation. Thus, the cells appeared to respond to the
early onset of IB stress by increasing cellular protein synthesis machinery. In contrast,
several substrate-specific transmembrane transport and catabolism genes were decreased
due to IB formation. Additionally, most of the affected transmembrane transport and
catabolism genes are regulated by Crp. Confounding these observations is the fact that
these substrates were not present in the growth medium. Thus, decreased expression of
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these genes may serve to alleviate the metabolic burden required to synthesize the cell
membrane components and enzymes needed for import and catabolism of these
substrates. The increased level of energy metabolism genes and electron transport chain
genes suggests that the cells were attempting to generate more ATP by enhancing the
electrochemical gradient required by ATP synthase; additionally, thiamine diphosphate,
an essential cofactor for energy metabolism enzymes, production was increased. Also,
over a third of genes identified as differentially expressed by IB formation are classified
as putative, or unknown, functionality. Taken together, the results of this study indicate
that IB formation in recombinant E. coli is a complex issue that not only induces the heatshock chaperones and proteases, but also directly causes the cells to increase protein and
energy synthesis while streamlining transport and catabolic processes; furthermore,
ethanol treatment mitigates all of these effects. Further study of the differentially
expressed putative genes could provide deeper insight into the dynamic response to IB
formation.
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CHAPTER SIX
FUTURE WORK

While the majority of the objectives of this study have been completed, future
work will include microscopy imaging of the VP1GFP and GFPCAT cultures to
independently confirm localization of CAT, GFP, and VP1. While VP1 and CAT are
both well-studied proteins immunofluorescence imaging provide proof of protein
localization in the IB and throughout the cell. Rhonda Powell and Dr. Terri Bruce will
conduct the immunofluorescence imaging experiments.
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APPENDIX A
DIFFERENTIALLY EXPRESSED GENES

Table A.1: Genes with differential expression listed in alphabetical order by gene
name (318 genes)
Table A.2: Genes with differential expression grouped by ontology terms (318
genes)

For both Table A.1 and Table A.2, the regression analysis slopes (p ≤ 0.05) are shown
(+/-; positive/negative slopes). The Tukey’s W pairwise comparisons fold changes (p ≤
0.05) are shown. Gene ontology (GO) terms are based on the classifications shown in
Figure 4.3.
For Tukey’s W pairwise comparison fold changes:
A = VP1GFP 60-minute induced versus VP1GFP 0-minute uninduced
B = VP1GFP 60-minute induced versus VP1GFP 60-minute uninduced
C = VP1GFP 60-minute induced versus GFPCAT 60-minute induced
D = Untreated VP1GFP 60-minute induced versus Ethanol-treated VP1GFP 60-minute
induced
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Table A.1: Genes with differential expression listed in alphabetical order by gene
name (318 genes)
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79

80

81

82

83

84

85

86

87

88

89

90

91

92

93

94

95

96

97

98

99

100

101

102

Table A.2: Genes with differential expression grouped by ontology terms (318 genes)

103

104

105

106

107

108

109

110

111

112

113

114

115

116

117

118

119

120

121

122

123

124

125

126

127

128

129

APPENDIX B
DYNAMIC GENE PROFILES

The dynamic gene expression profiles for selected gene groups referenced in the thesis
for E. coli VP1GFP and GFPCAT cultures. VP1GFP (,□), GFPCAT (▲,), and
ethanol-treated VP1GFP (♦, ◊); Uninduced (□, , ◊) and Induced (, ▲, ♦) are shown.
Gene expression levels were normalized to 100, which represents the “average” gene
expression intensity on the DNA microarray.
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Figure B.1: Gene expression profiles for 35 ribosomal subunit genes that did not
meet statistical significance. Gene expression profiles are shown for 35 ribosomal
subunit genes that did not meet statistical significance by ANOVA (p ≤ 0.10) and by
subsequent regression analysis (p ≤ 0.05) and/or Tukey’s W comparisons (p ≤ 0.05)
(average of 35 genes: rplBDFIKMOPSTUVWXY, rpmABCEFGH, rpsBCDEIJKOQRST,
and sra). VP1GFP (,□), GFPCAT (▲,), and ethanol-treated VP1GFP (♦, ◊);
Uninduced (□, , ◊) and Induced (, ▲, ♦) are shown. Gene expression levels were
normalized to 100.
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Figure B.2: Gene expression profiles for cofactor synthesis genes that were identified
for increased expression due to VP1GFP accumulation. Gene expression profiles are
shown for cofactor synthesis genes that were identified for increased expression due to
VP1GFP accumulation (average of nine genes: dxs, folC, hemL, ispEFG, and thiCMS).
All genes were identified by ANOVA analysis (p ≤ 0.10) and then were further identified
by regression analysis (p ≤ 0.05) and/or by Tukey’s W comparisons (p ≤ 0.05). VP1GFP
(,□), GFPCAT (▲,), and ethanol-treated VP1GFP (♦, ◊); Uninduced (□, , ◊) and
Induced (, ▲, ♦) are shown. Gene expression levels were normalized to 100.
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Figure B.3: Gene expression profiles for genes of pyruvate dehydrogenase complex
and of transketolase. Gene expression profiles are shown for genes of pyruvate
dehydrogenase complex (aceEF and lpd) and for transketolase (tktA) genes. VP1GFP
(,□), GFPCAT (▲,), and ethanol-treated VP1GFP (♦, ◊); Uninduced (□, , ◊) and
Induced (, ▲, ♦) are shown. Gene expression levels were normalized to 100.
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Figure B.4: Gene expression profiles for nine TCA cycle genes that were not
differentially expressed. Gene expression profiles are shown for nine TCA cycle genes
that were not differentially expressed (acnA, fumA, icd, lpd, mdh, sdhCD, sucAD). These
nine genes did not meet statistical significance by ANOVA (p ≤ 0.10) and by subsequent
regression analysis (p ≤ 0.05) and/or Tukey’s W comparisons (p ≤ 0.05). VP1GFP (,□),
GFPCAT (▲,), and ethanol-treated VP1GFP (♦, ◊); Uninduced (□, , ◊) and Induced
(, ▲, ♦) are shown. Gene expression levels were normalized to 100.
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Figure B.5: Gene expression profiles for ATP synthase genes. Gene expression
profiles are shown for ATP synthase genes. The atpF gene was identified by ANOVA
analysis (p ≤ 0.10) and then further identified by regression analysis (p ≤ 0.05), and the
remaining ATP synthase genes did not meet statistical significance (atpABCDEGH).
VP1GFP (,□), GFPCAT (▲,), and ethanol-treated VP1GFP (♦, ◊); Uninduced (□, ,
◊) and Induced (, ▲, ♦) are shown. Gene expression levels were normalized to 100.
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Figure B.6: Gene expression profiles for eight differentially expressed genes
involved in the electron transport chain. Gene expression profiles are shown for eight
differentially expressed genes (appC, dld, hyaDE, napD, narW, nuoCG) involved in the
electron transport chain. All genes were identified by ANOVA analysis (p ≤ 0.10) and
were further identified by regression analysis (p ≤ 0.05) and/or by Tukey’s W
comparisons (p ≤ 0.05). VP1GFP (,□), GFPCAT (▲,), and ethanol-treated VP1GFP
(♦, ◊); Uninduced (□, , ◊) and Induced (, ▲, ♦) are shown. Gene expression levels
were normalized to 100.
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Figure B.7: Gene expression profiles for ten differentially expressed transcription
regulation genes with decreased expression due to VP1GFP production. Gene
expression profiles are shown for ten differentially expressed transcription regulation
genes with decreased expression in response to VP1GFP production (average of ten
genes: atoS, dcuR, hcaR, lexA, lysR, nadR, rcnR, rfaH, rhaR, and sdiA). All genes were
identified by ANOVA analysis (p ≤ 0.10) and were further identified by regression
analysis (p ≤ 0.05) and/or by Tukey’s W comparisons (p ≤ 0.05). VP1GFP (,□),
GFPCAT (▲,), and ethanol-treated VP1GFP (♦, ◊); Uninduced (□, , ◊) and Induced
(, ▲, ♦) are shown. Gene expression levels were normalized to 100.

137

Figure B.8: Gene expression profiles for three differentially expressed transcription
regulation genes with increased expression due to VP1GFP production. Gene
expression profiles are shown for three differentially expressed transcription regulation
genes with increased expression due to VP1GFP production (kdgR, nusA, phoQ). All
genes were identified by ANOVA analysis (p ≤ 0.10) and were further identified by
regression analysis (p ≤ 0.05) and/or by Tukey’s W comparisons (p ≤ 0.05). VP1GFP
(,□), GFPCAT (▲,), and ethanol-treated VP1GFP (♦, ◊); Uninduced (□, , ◊) and
Induced (, ▲, ♦) are shown. Gene expression levels were normalized to 100.
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